We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$101B
AUM Growth
+$2.01B
Cap. Flow
-$3.82B
Cap. Flow %
-3.77%
Top 10 Hldgs %
21.46%
Holding
3,342
New
87
Increased
1,934
Reduced
957
Closed
183

Top Buys

Rank Stock Value
1
VALE icon
Vale
VALE
+$90.8M
2
CMCSA icon
Comcast
CMCSA
+$75.5M
3
MELI icon
Mercado Libre
MELI
+$72.9M
4
DHR icon
Danaher
DHR
+$51M
5
PWR icon
Quanta Services
PWR
+$46.2M

Sector Composition

Rank Sector Weight
1 Technology 25.7%
2 Healthcare 15.68%
3 Financials 13.32%
4 Consumer Discretionary 9.98%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNET
3026
VNET Group
VNET
$2.04B
$44.1K ﹤0.01%
15,213
-147,329
-91% -$448K
RIDE
3027
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$42.5K ﹤0.01%
19,968
+9,910
+99% +$52K
HYLN icon
3028
Hyliion Holdings
HYLN
$672M
$37.6K ﹤0.01%
22,538
-62,056
-73% -$105K
CAN
3029
Canaan Creative
CAN
$132M
$34.9K ﹤0.01%
16,400
-8
-0% -$19
DDL
3030
Dingdong
DDL
$542M
$32.4K ﹤0.01%
10,486
ESPR
3031
DELISTED
Esperion Therapeutics
ESPR
$28.2K ﹤0.01%
20,307
-46,292
-70% -$64.6K
BNAIW
3032
Brand Engagement Network Warrant
BNAIW
$26.7K ﹤0.01%
+26,666
New +$1.58K
VST.WS.A
3033
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$26.4K ﹤0.01%
439,257
INO icon
3034
Inovio Pharmaceuticals
INO
$57.3M
$25.5K ﹤0.01%
4,750
-25,627
-84% -$207K
ABSI icon
3035
Absci
ABSI
$1.34B
$25.3K ﹤0.01%
+16,640
New +$26.8K
CRGE
3036
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$23.3K ﹤0.01%
23,738
-88,196
-79% -$89.6K
AMRN
3037
Amarin Corp
AMRN
$297M
$13.5K ﹤0.01%
568
CISS
3038
C3is
CISS
$166K
0
DOYU
3039
DouYu International Holdings
DOYU
$142M
$11.2K ﹤0.01%
1,067
SDC
3040
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$6.01K ﹤0.01%
11,334
ACB
3041
Aurora Cannabis
ACB
$175M
-35,223
Closed -$246K
ACET icon
3042
Adicet Bio
ACET
$86.4M
-835
Closed -$76.9K
ADV icon
3043
Advantage Solutions
ADV
$527M
-1,999
Closed -$79K
AEVA
3044
Aeva Technologies
AEVA
$1.26B
-14,170
Closed -$84.3K
ALT icon
3045
Altimmune
ALT
$583M
-41,372
Closed -$175K
ALXO icon
3046
ALX Oncology
ALXO
$260M
-21,297
Closed -$96.3K
AMLP icon
3047
Alerian MLP ETF
AMLP
$13B
-627,013
Closed -$24.2M
AMRX icon
3048
Amneal Pharmaceuticals
AMRX
$6.02B
-61,879
Closed -$86K
ATRA icon
3049
Atara Biotherapeutics
ATRA
$77M
-3,802
Closed -$276K
AUDC icon
3050
AudioCodes
AUDC
$249M
-19,946
Closed -$301K

Similar funds

Credit Suisse's Q2 2023 Portfolio in Review

As of Q2 2023, Credit Suisse held 3,342 positions worth $101B, up 2% from $99.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Credit Suisse withdrew a net $3.82B in Q2 2023, closing 183 positions and reducing 957 holdings. Its most notable exit was Zai Lab, an estimated $73.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in ProShares UltraPro Short QQQ worth $4.03M.

  • Credit Suisse's largest Q2 2023 buy was ProShares UltraPro Short QQQ: 8,529 shares worth $4.03M.
  • Credit Suisse added most to Vale in Q2 2023, an estimated $90.8M increase.
  • Credit Suisse's biggest Q2 2023 reduction was Microsoft, cutting an estimated $323M.
  • Credit Suisse fully exited Zai Lab in Q2 2023, selling an estimated $73.2M.
  • Credit Suisse's ten largest holdings make up 21% of its $101B portfolio in Q2 2023.
  • Credit Suisse opened 87 new positions and closed 183 in Q2 2023.
  • Credit Suisse's portfolio value rose 2% quarter-over-quarter to $101B.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.